Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Neurofibromatosis 2017 NINDS 1R35NS097211-01 Defining the Mechanistic Basis for Neurofibromatosis-1 Nervous System Disease Heterogeneity GUTMANN, DAVID WASHINGTON UNIVERSITY MO $683,722
Neurofibromatosis 2017 NCI 5R01CA072597-18 Oncogenic Events in Thyroid Neoplasia FAGIN, JAMES SLOAN-KETTERING INST CAN RESEARCH NY $428,500
Neurofibromatosis 2017 NCI 5R01CA111754-12 Elucidating the Regulation and Function of the NF1 tumor suppressor CICHOWSKI, KAREN BRIGHAM AND WOMEN'S HOSPITAL MA $316,635
Neurofibromatosis 2017 NINDS 5R01NS077952-05 Mechanisms of cell contact inhibition and their dysregulation in cancer. KISSIL, JOSEPH SCRIPPS FLORIDA FL $420,000
Neurofibromatosis 2017 NHLBI 5R01HL127339-03 The role of NF2 in myocardial ischemia and reperfusion injury DELRE, DOMINIC RBHS-NEW JERSEY MEDICAL SCHOOL NJ $397,500
Neurofibromatosis 2017 NCI 5R35CA197709-02 New Ways of Targeting K-Ras MCCORMICK, FRANK UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $918,748
Neurofibromatosis 2017 NINDS 5R01NS086938-04 Function & regulation of Hippo pathway effectors YAP/TAZ during brain development CAO, XINWEI ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $382,813
Neurofibromatosis 2017 NCATS 9R13TR002095-02 Enhancing patient engagement in neurofibromatosis clinical trials PLOTKIN, SCOTT MASSACHUSETTS GENERAL HOSPITAL MA $10,017
Neurofibromatosis 2017 NINDS 5R01NS091037-03 Brain Dysfunction in Neurofibromatosis RATNER, NANCY CINCINNATI CHILDRENS HOSP MED CTR OH $309,792
Neurofibromatosis 2017 NINDS 5R37NS083580-04 Ras Proteins in Nerve Tumorigensis RATNER, NANCY CINCINNATI CHILDRENS HOSP MED CTR OH $390,000
Neurofibromatosis 2017 NCI 5R01CA142928-08 Targeting the Kinome in Neurofibromatosis type 1 CHERNOFF, JONATHAN RESEARCH INST OF FOX CHASE CAN CTR PA $434,625
Neurofibromatosis 2017 NCI 5U01CA202943-02 Developing a translational pipeline for NF1-mutant malignancies CICHOWSKI, KAREN BRIGHAM AND WOMEN'S HOSPITAL MA $380,076
Neurofibromatosis 2017 NCI 5R01CA195692-03 Leveraging Genetically-Engineered Mice to Optimize Pediatric Glioma Management GUTMANN, DAVID WASHINGTON UNIVERSITY MO $551,530
Neurofibromatosis 2017 NINDS 5R01NS097233-02 miR-155 and RUNX function in neurofibroma tumorigenesis and therapy WU, JIANQIANG CINCINNATI CHILDRENS HOSP MED CTR OH $341,250
Neurofibromatosis 2017 NCI 5R01CA153354-06 Study of Anti-Survival signals in NF1 CHEN, CHANGYAN NORTHEASTERN UNIVERSITY MA $225,443
Neurofibromatosis 2017 NINDS 5R01NS086219-04 Disordered Regulation of Wnt/beta-catenin Signaling in MPNST Development and Maintenance LARGAESPADA, DAVID UNIVERSITY OF MINNESOTA MN $491,889
Neurofibromatosis 2017 NINDS 5F30NS096796-02 Cytokine signaling in neurofibroma development FLETCHER, JONATHAN CINCINNATI CHILDRENS HOSP MED CTR OH $40,644
Neurofibromatosis 2017 NICHD 1F31HD089606-01A1 Social Competence in Youth with Neurofibromatosis Type 1 MCCURDY, MARK DREXEL UNIVERSITY PA $44,044
Neurofibromatosis 2017 NCI 5R01CA201130-02 Phase II trial of mTORC1/mTORC2 inhibitor AZD2014 for sporadic meningioma RAMESH, VIJAYA MASSACHUSETTS GENERAL HOSPITAL MA $401,017
Neurofibromatosis 2017 NCI 5R01CA214146-02 DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA GUTMANN, DAVID WASHINGTON UNIVERSITY MO $348,844
Neurofibromatosis 2017 NINDS 5R01NS095411-03 Targeting Tumors with NF1 Loss SANCHEZ, YOLANDA DARTMOUTH COLLEGE NH $544,581
Neurofibromatosis 2017 NCI 5R21CA208723-02 (PQ 6) Exploiting Frequent Alterations in the PRC2 Complex to Distinguish Benign Neurofibromas from Malignant Peripheral Nerve Sheath Tumors BETTEGOWDA, CHETAN JOHNS HOPKINS UNIVERSITY MD $177,852
Neurofibromatosis 2017 NICHD 5R01HD089474-02 Neurobiology and Treatment of Reading Disability in NF1 CUTTING, LAURIE VANDERBILT UNIVERSITY TN $629,726
Neurofibromatosis 2017 NCI 5U54CA196519-03 7036 Core A: Omics Core JOHNSON, GARY UNIV OF NORTH CAROLINA CHAPEL HILL NC $391,146
Neurofibromatosis 2017 NCI 5U54CA196519-03 7037 Core B: Biospecimen/Pathology Core FOROUD, TATIANA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $123,510
Neurofibromatosis 2017 NCI 5U54CA196519-03 7038 Core C: Administrative Core CLAPP, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $46,376
Neurofibromatosis 2017 NCI 5U54CA196519-03 7039 Project 1: Molecular and Genetic Features Across Mouse and Human Plexiform Neurofibromas to Inform Clinical Trials CLAPP, DAVID INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $135,478
Neurofibromatosis 2017 NCI 5U54CA196519-03 7040 Project 2: Targeted Therapies for Malignant Peripheral Nerve Sheath Tumors SKAPEK, STEPHEN UT SOUTHWESTERN MEDICAL CENTER TX $441,855
Neurofibromatosis 2017 NCI 5U54CA196519-03 7041 Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $419,407
Neurofibromatosis 2017 NCI 5U54CA196519-03 7042 Project 4: Secondary Cancers Among NF1 Cancer Survivors NAKAMURA, JEAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $502,899
Neurofibromatosis 2017 NCI 5U54CA196519-03 7043 Developmental Research Program SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $117,214
Neurofibromatosis 2017 NCI 5U54CA196519-03 7044 Career Development Program SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $93,898
Neurofibromatosis 2017 NINDS 5R21NS096402-02 Functional analysis of pathogenic mutations in Neurofibromatosis Type-1 (NF1) WALKER, JAMES MASSACHUSETTS GENERAL HOSPITAL MA $201,725
Neurofibromatosis 2017 NCI 5R01CA164295-06 Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom ZAGZAG, DAVID NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $325,863
Neurofibromatosis 2017 NIDCD 5R01DC015824-02 Mechanisms of sensorineural hearing loss: secreted factors STANKOVIC, KONSTANTINA MASSACHUSETTS EYE AND EAR INFIRMARY MA $425,000
Neurofibromatosis 2017 NINDS 5R37NS096359-02 Molecular and signaling mechanisms of peripheral nerve sheath tumorigenesis LU, QING CINCINNATI CHILDRENS HOSP MED CTR OH $529,965
Neurofibromatosis 2017 NINDS 1R21NS099417-01A1 Development and validation of a genetically engineered model of neurofibromatosis type 2 to facilitate discovery of neurotherapeutics KISSIL, JOSEPH SCRIPPS FLORIDA FL $477,230
Neurofibromatosis 2017 NINDS 1R01NS097237-01A1 Mechanisms of Nf1 pathophysiology underlying hyperactivity TOMCHIK, SETH SCRIPPS FLORIDA FL $417,448
Neurofibromatosis 2017 NINDS 2R01NS034783-19A1 Function of NF2/Merlin in regulation of the Hippo/Salvador/Warts growth control pathway FEHON, RICHARD UNIVERSITY OF CHICAGO IL $493,194
Neurofibromatosis 2017 NCATS 1R13NS103421-01 Children's Tumor Foundation 2017 Neurofibromatosis (NF) Conference SHERMAN, LAWRENCE CHILDREN'S TUMOR FOUNDATION NY $7,500
Neurofibromatosis 2017 NINDS 1R13NS103421-01 Children's Tumor Foundation 2017 Neurofibromatosis (NF) Conference SHERMAN, LAWRENCE CHILDREN'S TUMOR FOUNDATION NY $15,000
Neurofibromatosis 2017 NINDS 2R01NS028840-26A1 Mitogenic Activities in Neurofibromatosis RATNER, NANCY CINCINNATI CHILDRENS HOSP MED CTR OH $416,302
Neurofibromatosis 2017 NCI 1ZIACP010144-19 Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes PEMOV, ALEXANDER NIH $9,903,769
Neurofibromatosis 2017 NEI 1ZIAEY000388-16 Neuro-ophthalmic Mechanisms Of Disease FITZGIBBON, EDMOND NIH $259,906
Neurofibromatosis 2017 NCI 1ZIABC010801-11 Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes WIDEMANN, BRIGITTE NIH $1,001,699
Neurofibromatosis 2017 NCI 1ZIABC011470-06 Development of Natural Product Leads as Anticancer Therapeutics BEUTLER, JOHN NIH $435,393
Neurofibromatosis 2017 NCI 1ZIABC011734-02 Genomic dissection of tumor heterogeneity and progression SHERN, JOHN NIH $294,563
Neurofibromatosis 2017 NCI 1ZIABC011754-01 Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1 REILLY, KARLYNE NIH $644,656
Neurofibromatosis 2017 NCI 1ZIASC010354-18 Clinical Development of Novel Drugs for Children with Refractory Cancers WIDEMANN, BRIGITTE NIH $667,799
Neurofibromatosis 2017 NCI 1ZIDBC011517-05 Pediatric Oncology Branch Behavioral Science Core GLOD, JOHN NIH $1,247,135
Neurofibromatosis 2017 NINDS 1ZIANS003053-10 Neuro-oncology of Familial Neoplasia Syndromes YOULE, RICHARD NIH $646,313
Neurofibromatosis 2017 NINDS 1ZIANS003132-06 Neurooncology of Benign Central and Peripheral Nervous System Tumors HEISS, JOHN NIH $588,894
Neurofibromatosis 2017 NHGRI 1ZIAHG200330-13 Comparative Genomics Analysis Unit Research MULLIKIN, JAMES NIH $1,224,515


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer